Call Us08037400111
Zinc Carnosine

Zinc Carnosine

25.00 - 50.00 INR

Product Details:

  • HS Code 74112100
  • Shelf Life 1-3 Years
  • Chemical Name Zinc Carnosine
  • CAS No 1405-89-6
  • Purity(%) 98%
  • Supply Ability : 1000 Kilograms Per Day
  • Click to view more
X

Price And Quantity

  • 25.00 - 50.00 INR
  • 25 Kilograms

Product Specifications

  • 1-3 Years
  • 98%
  • 1405-89-6
  • Zinc Carnosine
  • 74112100

Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 1000 Kilograms Per Day
  • 7 Days
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

We have constructed a sound processing unit, helps us in offering Zinc Carnosine. It is used with other medications to prevent and treat malaria caused by mosquito bites. The drug is used after other medications such as chloroquine have killed the malaria parasites living inside red blood cells. Zinc Carnosine then kills the malaria parasites living in other body tissues. This prevents the return of the infection. This drug belongs to a class of drugs known as antimalarials. We make available this drug for clients in different quantity packaging options and at reasonable prices.

  • CAS NO:107667-60-7
  • Formula: C9H12N4O3Zn
  • Molecular Weight: 289.52
  •  Appearance : White or Pale Yellowish
  • Carnosine Content :76.0-80.0%
  • Zinc Content:21.5-23.0%
  • Zinc Carnosine
  • CAS No.:107667-60-7
  • Purity:99%
  • Grade:USP31
  • shanghai soyoung


Zinc L-carnosine, often simply called zinc carnosine, and also known as polaprezinc, is a mucosal protective chelate compound of zinc and L-carnosine invented by Hamari Chemicals, Ltd. It is a quadridentate 1:1 complex of a polymeric nature.
Zinc carnosine (ZnC) is a health food product claimed to possess health‐promoting and gastrointestinal supportive activity. Scientific evidence underlying these claims is, however, limited.

ZnC stimulated migration and proliferation of cells in a dose‐dependent manner (maximum effects in both assays at 100 µmol/l using HT29 cells), causing an approximate threefold increase in migration and proliferation (both p<0.01). Oral ZnC decreased gastric (75% reduction at 5 mg/ml) and small‐intestinal injury (50% reduction in villus shortening at 40 mg/ml; both p<0.01). In volunteers, indomethacin caused a threefold increase in gut permeability in the control arm; lactulose:rhamnose ratios were (mean (standard error of mean)) 0.35 (0.035) before indomethacin treatment and 0.88 (0.11) after 5 days of indomethacin treatment (p<0.01), whereas no significant increase in permeability was seen when ZnC was coadministered.
 


SHREEJI PHARMA INTERNATIONAL

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.